Implantable Technologies
Royal Society of Chemistry (Verlag)
978-1-83916-222-0 (ISBN)
Status of Implantable and Long-acting Injectable Technologies;
Developing Complex Dosage Forms of Long- acting Biologics for the Eye: Current State, Challenges, and Opportunities;
Monolithic Devices for Sustained Delivery of Protein Therapeutics for Ocular Disease;
Sustained Delivery of Ocular Protein Therapeutics;
Development of Risperidone Implant Formulations (DLP-114) for Long-term Maintenance Treatment of Schizophrenia;
In-line Extrusion Process and Product Evaluation of ProNeura® by Near-infrared Spectroscopy;
Addressing Immunogenicity for Implantable Drug-delivery Devices and Long-acting Injectables, Including Pharmacokinetic and Pharmacodynamic Correlations;
Characterization Methods for Parenteral Peptide Controlled Release Drug Delivery Systems;
Parenteral Delivery of Therapeutic Proteins, Peptides and Small Molecules Using Biodegradable Silica;
Development of User-initiated Vaginal Dosage Forms;
Three-dimensional Printed Implantable Products;
Erscheinungsdatum | 28.10.2021 |
---|---|
Reihe/Serie | Drug Development and Pharmaceutical Science ; Volume 1 |
Verlagsort | Cambridge |
Sprache | englisch |
Maße | 156 x 234 mm |
Gewicht | 629 g |
Themenwelt | Naturwissenschaften ► Biologie ► Genetik / Molekularbiologie |
Naturwissenschaften ► Chemie ► Organische Chemie | |
Technik | |
ISBN-10 | 1-83916-222-8 / 1839162228 |
ISBN-13 | 978-1-83916-222-0 / 9781839162220 |
Zustand | Neuware |
Haben Sie eine Frage zum Produkt? |
aus dem Bereich